In this study, we aimed to perform a combined analysis of PIK3CA mutations and CN gain in three large and well characterized BC cohorts, namely METABRIC19,20, MSK-breast cancer 2018 (MSK-2018)21 and TCGA-BRCA (TCGA)22. The gene discussed is PIK3CA; the disease is breast carcinoma.